Literature DB >> 7359119

Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

J Balldin, S Edén, A K Granérus, K Modigh, A Svanborg, J Wålinder, L Wallin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7359119     DOI： 10.1007/bf01256635

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  25 in total

1.  Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure discharge.

Authors:  B CRONHOLM; J O OTTOSSON
Journal:  Acta Psychiatr Scand Suppl       Date:  1960

2.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

3.  Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks.

Authors:  S Edén; K Modigh
Journal:  Brain Res       Date:  1977-07-01       Impact factor: 3.252

4.  Plasma levodopa and the "on-off" effect.

Authors:  D B Caine; L E Claveria; J G Allen
Journal:  Adv Neurol       Date:  1974

5.  Long-term side-effects of levodopa.

Authors:  A Barbeau
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

6.  Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines.

Authors:  K Modigh
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

7.  Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

Authors:  T Lee; P Seeman; A Rajput; I J Farley; O Hornykiewicz
Journal:  Nature       Date:  1978-05-04       Impact factor: 49.962

8.  Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

Authors:  K S Price; I J Farley; O Hornykiewicz
Journal:  Adv Biochem Psychopharmacol       Date:  1978

9.  Improvement of Parkinsonism in depressed patients treated with ECT.

Authors:  Z M Lebensohn; R B Jenkins
Journal:  Am J Psychiatry       Date:  1975-03       Impact factor: 18.112

10.  Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.

Authors:  A Randrup; C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530
View more
  13 in total

1.  Cell implantation in Parkinson's disease.

Authors:  P Madeley; J L Boyd; C A Biggins; R H Mindham; E G Spokes
Journal:  BMJ       Date:  1990-09-15

Review 2.  Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.

Authors:  F Fregni; D K Simon; A Wu; A Pascual-Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Parkinson's disease.

Authors: 
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

4.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome.

Authors:  C Ward; G M Stern; R T Pratt; P McKenna
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice.

Authors:  X Z Hao; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 8.  Treatment of psychosis in Parkinson's disease: safety considerations.

Authors:  Hubert H Fernandez; Martha E Trieschmann; Joseph H Friedman
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

10.  Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behaviour.

Authors:  P J Cowen; D J Nutt; C C Batts; A R Green; D J Heal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.